Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (6): 10-14.doi: 10.6040/j.issn.1671-7554.0.2021.0324
Previous Articles Next Articles
LUO Xianghang, ZHOU Ruoyu
CLC Number:
| [1] Qaseem A, Forciea MA, McLean RM, et al. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians [J]. Ann Intern Med, 2017, 166(11): 818-839. [2] Feng X, McDonald JM. Disorders of bone remodeling [J]. Annu Rev Pathol, 2011, 6: 121-145. doi:10.1146/annure-pathol-011110-130203. [3] Kruse HP, Kuhlencordt F. Pathogenesis and natural course of primary osteoporosis [J]. Lancet, 1980, 1(8163): 280-282. [4] Walker-Bone K. Recognizing and treating secondary osteoporosis [J]. Nat Rev Rheumatol, 2012, 8(8): 480-492. [5] Hadjidakis DJ, Androulakis. Bone remodeling [J]. Ann N Y Acad Sci, 2006, 1092: 385-396. doi: 10.1196/annals.1365.035. [6] Karsenty G. The central regulation of bone remodeling [J]. Trends Endocrinol Metab, 2000, 11(10): 437-439. [7] Zhang L, Su P, Xu C, et al. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression [J]. J Pineal Res, 2010, 49(4): 364-372. [8] Li CJ, Xiao Y, Yang M, et al. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging [J]. J Clin Invest, 2018, 128(12): 5251-5266. [9] Ortinau LC, Wang H, Lei K, et al. Identification of functionally distinct Mx1+αSMA+ periosteal skeletal stem cells [J]. Cell Stem Cell, 2019, 25(6): 784-796.e785. [10] Debnath S, Yallowitz AR, McCormick J, et al. Discovery of a periosteal stem cell mediating intramembranous bone formation [J]. Nature, 2018, 562(7725): 133-139. [11] Han Y, You X, Xing W, et al. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts [J]. Bone Res, 2018, 6: 16. doi: 10.1038/s41413-018-0019-6. eCollection 2018. [12] Al Rifai O, Chow J, Lacombe J, et al. Proprotein convertase furin regulates osteocalcin and bone endocrine function [J]. J Clin Invest, 2017, 127(11): 4104-4117. [13] Wu M, Chen G, Li YP. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease [J]. Bone Res, 2016, 4: 16009. doi:10.1038/boneres.2016.9. [14] McGregor NE, Murat M, Elango J, et al. IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis [J]. J Biol Chem, 2019, 294(19): 7850-7863. [15] 张猛, 牛泽锋, 王翠杰, 等. 破骨细胞活性及其调节因子的研究进展[J]. 脊柱外科杂志, 2018, 16(3): 179-182. ZHANG Meng, NIU Zefeng, WANG Cuijie, et al. Research progress of osteoclast activity and its regulating factors [J]. Journal of Spinal Surgery, 2018, 16(3): 179-182. [16] Maré A, DHaese PC, Verhulst A. The role of sclerostin in bone and ectopic calcification [J]. Int J Mol Sci, 2020, 21(9): 3199. doi: 10.3390/ijms21093199. [17] Bullock WA, Hoggatt AM, Horan DJ, et al. Lrp4 mediates bone homeostasis and mechanotransduction through interaction with sclerostin in vivo [J]. iScience, 2019, 20: 205-215. doi: 10.1016/j.isci.2019.09.023. [18] Liu W, Wang Z, Yang J, et al. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice [J]. Open Biol, 2019, 9(5): 180262. doi: 10.1098/rsob.180262. [19] Fijalkowski I, Geets E, Steenackers E, et al. A novel domain-specific mutation in a sclerosteosis patient suggests a role of LRP4 as an anchor for sclerostin in human bone [J]. J Bone Miner Res, 2016, 31(4): 874-881. [20] Delgado-Calle J, Sato AY, Bellido T, Role and mechanism of action of sclerostin in bone [J]. Bone, 2017, 96: 29-37. doi: 10.1016/j.bone.2016.10.007. [21] Morgan EF, Unnikrisnan GU, Hussein AI. Bone mechanical properties in healthy and diseased states [J]. Annu Rev Biomed Eng, 2018, 20: 119-143. doi: 10.1146/annurev-bioeng-062117-121139. [22] Lee WC, Guntur AR, Long F, et al. Energy metabolism of the osteoblast: implications for osteoporosis [J]. Endocr Rev, 2017, 38(3): 255-266. [23] Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone [J]. Nature, 2014, 507(7492): 323-328. [24] Yang M, Li CJ, Xiao Y, et al. Ophiopogonin D promotes bone regeneration by stimulating CD31(hi)EMCN(hi)vessel formation [J]. Cell Prolif, 2020, 53(3): e12784. doi: 10.1111/cpr.12784. [25] Yang M, Li CJ, Sun X, et al. MiR-497-195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1α activity [J]. Nat Commun, 2017, 8: 16003. doi: 10.1038/ncomms16003. [26] Ralston SH, Uitterlinden AG. Genetics of osteoporosis [J]. Endocr Rev, 2010, 31(5): 629-662. [27] Zhang L, Yin X, Wang J, et al. Associations between VDR gene polymorphisms and osteoporosis risk and bone mineral density in postmenopausal women: a systematic review and Meta-analysis [J]. Sci Rep, 2018, 8(1): 981. [28] 赵航, 马慧娟, 王超. 骨质疏松症相关基因研究进展[J]. 实用老年医学, 2019, 33(6): 9-13. [29] Zhu X, Zheng H, Factors influencing peak bone mass gain [J]. Front Med, 2021, 15(1): 53-69. [30] Windahl SH, Börjesson AE, Farman HH, et al. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice [J]. Proc Natl Acad Sci U S A, 2013, 110(6): 2294-2299. [31] Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton [J]. Trends Endocrinol Metab, 2012, 23(11): 576-581. [32] Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts [J]. Cell, 2007, 130(5): 811-823. [33] Almeida M, Laurent MR, Dubois V, et al. Estrogens and androgens in skeletal physiology and pathophysiology [J]. Physiol Rev, 2017, 97(1): 135-187. [34] Li CJ, Cheng P, Liang MK, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation [J]. J Clin Invest, 2015, 125(4): 1509-1522. [35] 王洪复, 于明香. 老年人成骨细胞骨形成功能的衰退与治疗[J]. 国外医学(内分泌学分册), 2003, 23(2): 79-80,97. [36] Hemmatian H, Bakker AD, Klein-Nulend J, et al. Aging, osteocytes, and mechanotransduction [J]. Curr Osteoporos Rep, 2017, 15(5): 401-411. [37] Cai D, Khor S. “Hypothalamic Microinflammation” Paradigm in Aging and Metabolic Diseases [J]. Cell Metab, 2019, 30(1): 19-35. [38] Zhang G, Li J, Purkayastha S, et al. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH [J]. Nature, 2013, 497(7448): 211-216. [39] Xiao YZ, Yang M, Xiao Y, et al. Reducing hypothalamic stem cell senescence protects against aging-associated physiological decline [J]. Cell Metab, 2020, 31(3): 534-548.e535. [40] Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal andextraskeletal actions of Vitamin D: current evidence and outstanding questions [J]. Endocr Rev, 2019, 40(4): 1109-1151. [41] Polzonetti V, Pucciarelli S, Vincenzetti S, et al. Dietary intake of Vitamin D from dairy products reduces the risk of osteoporosis [J]. Nutrients, 2020, 12(6): 1743. doi: 10.3390/nu12061743. [42] Hardcastle SA, Yahya F, Bhalla AK. Pregnancy-associated osteoporosis: a UK case series and literature review [J]. Osteoporos Int, 2019, 30(5): 939-948. [43] Papageorgiou M, Sathyapalan T, Schutte R. Muscle mass measures and incident osteoporosis in a large cohort of postmenopausal women [J]. J Cachexia Sarcopenia Muscle, 2019, 10(1): 131-139. [44] Li G, Zhang L, Wang D, et al. Muscle-bone crosstalk and potential therapies for sarco-osteoporosis [J]. J Cell Biochem, 2019, 120(9): 14262-14273. [45] McDonald MM, Khoo WH, Ng PY, et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption [J]. Cell, 2021, 184(5): 1330-1347. [46] Fabre S, Funck-Brentano T, Cohen-Solal M. Anti-sclerostin antibodies in osteoporosis and other bone diseases [J]. J Clin Med, 2020, 9(11):3439. doi: 10.3390/jcm9113439. [47] Asadipooya K, Weinstock A. Cardiovascular outcomes of romosozumab and protective role of alendronate [J]. Arterioscler Thromb Vasc Biol, 2019, 39(7): 1343-1350. [48] Ardura JA, Portal-Núñez S, Alonso V, et al. Handling parathormone receptor type 1 in skeletal diseases: realities and expectations of abaloparatide [J]. Trends Endocrinol Metab, 2019, 30(10): 756-766. |
| [1] | CHEN Shihong, JIANG Dongqing, ZHUANG Xianghua, LI Xiaobo, PAN Zhe, SUN Aili, LOU Nengjun, WANG Dianhui, DU Jiaojiao, SONG Yuwen. Primary biliary cholangitis with bone pain as the main manifestation: a case report [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 98-102. |
| [2] | Guowei TAO,Fang WANG,Xiangyi DONG,Yaxuan XU,Linli ZHAO,Beibei HU. Diagnosis of adenomyosis using ultrasound and magnetic resonance imaging [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 56-65. |
| [3] | Guoyun WANG,Zangyu PAN. Research progress of animal models of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 48-55. |
| [4] | Sunwei GUO,Xishi LIU. Cracking the enigma of pathogenesis and pathophysiology of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 6-19. |
| [5] | YANG Lizhi, SUN Xiao, SHANG Mengmeng, GUO Lu, SHI Dandan, LI Jie. C-TIRADS-based nomogram for malignant risk prediction of thyroid nodules [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 64-69. |
| [6] | SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50. |
| [7] | GONG Yu, GAO Zhen, WANG Huqing, YANG Jingwen, ZHANG Guilian, ZHAN Shuqin, ZHANG Ru, WU Haiqin. Clinical and imaging characteristics of 4 cases of secondary hypertrophic olivary degeneration [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 37-42. |
| [8] | ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95. |
| [9] | FENG Baomin, WANG Zhou, XU Han, LI Jiacun, YU Qiaowen, XIU Jianjun. Clinical and imaging features of 19 cases of anti-myelin oligodendrocyte glycoprotein-IgG antibody associated disorders [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 45-50. |
| [10] | SONG Yufeng, NING Hao, YAO Zhigang, WU Haihu, LIU Feifan, LYU Jiaju. Clinical and imaging features of adrenal cavernous hemangioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 37-42. |
| [11] | LI Xiangze, WANG Xianming, SONG Gesheng, CUI Jing, SUN Kai, WANG Haochen, WANG Tiancheng, HAN Shaoqi, TIAN Hu. Hepatic epithelioid hemangioendothelioma complicated with hepatitis B cirrhosis: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 89-95. |
| [12] | LYU Li, JIANG Lu, CHEN Shihong, ZHUANG Xianghua, SONG Yuwen, WANG Dianhui, AN Wenjuan, LI Qian, PAN Zhe. Related factors of osteoporosis in 210 postmenopausal women with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 19-25. |
| [13] | Ping LIU,Yuwen SONG,Ping WANG,Guangwei TIAN,Fengjie ZHENG,Li LYU,Jiaojiao DU,Jing ZHANG,Xianghua ZHUANG,Shihong CHEN. Correlation between vitamin D deficiency and depression in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 51-56,102. |
| [14] | CHENG Xiaoguang, LU Yanhui. Osteoporosis in men: a chronically overlooked problem [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 5-9. |
| [15] | Minqi LI,Juan DU,Panpan YANG,Yuying KOU,Shanshan LIU. Research progress of oxidative stress regulating osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 16-24. |
|
